| 英文名称 | 中文名称 | CAS | MF |
|
(2R,3E)-4-Methyl-5-phenyl-3-penten-2-ol
|
|
|
C12H16O
|
|
(5R,6E)-6-[(1-Methyl-1H-1,2,3-triazol)-4-yl]methylene-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
|
|
|
C11H10N4O3
|
|
(1R,2E)-1α-Methyl-3,3-difluoro-4,4-dichloro-2-ethylidenecyclobutane
|
|
|
|
|
[R,E,(+)]-2-Methyl-2-phenyl-4-hexenoic acid
|
|
|
C13H16O2
|
|
[1R,(+)]-3α-[(E)-2-Methoxycarbonyl-1-propenyl]-2,2-dimethylcyclopropanecarboxylic acid
|
第二菊酸
|
26767-71-5
|
C11H16O4
|
|
(R,E)-5-Methyl-1,3-heptadiene
|
|
|
C8H14
|
|
(2α,17R,19E)-11-Methoxy-19,20-didehydro-17-hydroxyajmalan-16-carboxylic acid methyl ester
|
|
|
|
|
(2R,4E)-2-Methyl-4-hexenal
|
|
|
C7H12O
|
|
[(R,E)-1-(Methoxymethoxy)-2-pentenyl]tributylstannane
|
|
|
C19H40O2Sn
|
|
rfb protein
|
|
|
|
|
rel-2α*-Propyl-3β*-methyloxirane
|
|
6124-91-0
|
C6H12O
|
|
rel-2α*-Propyl-3α*-methyloxirane
|
|
6124-90-9
|
C6H12O
|
|
rel-(3R*)-1,2,3,3a,5a,6,7,8-Octahydro-6-methylene-N,3aβ*,5aα*-trimethyl-N-phenylcyclopenta[c]pentalene-3β*-carboxamide
|
|
|
|
|
Rf-(CH2-CH2-O)nR Rf=CH3 and other function group
|
|
|
|
|
Rf-(CH2-CH2-O)nH Rf=F(CF2CF2)m-SO-N(C2H5)-(m=2-20)
|
|
|
|
|
rel-(1R*)-1β*,2α*-Dibromo-1,2-dihydrobenzocyclobutene
|
|
14420-75-8
|
C8H6Br2
|
|
rel-(1R*)-2α*-Isopropyl-N,5α*-dimethyl-N-phenylcyclopentane-1β*-carboxamide
|
|
|
|
|
REN-293
|
|
76567-41-4
|
C9H13NO3
|
|
rel-(3S*)-1,2,3,3a,5a,6,7,8-Octahydro-6-methylene-N,3aβ*,5aα*-trimethyl-N-phenylcyclopenta[c]pentalene-3α*-carboxamide
|
|
|
|
|
rel-(1R*)-N,2β*-Dimethyl-N-phenylcyclopentane-1β*-carboxamide
|
|
|
|
|
rel-(2R*)-2-(3-Phenoxyphenyl)propionic acid methyl ester
|
|
74793-79-6
|
|
|
rel-(1R*)-1-Phenyl-1α*,2β*-cyclohexanediol
|
|
27167-34-6
|
C12H16O2
|
|
Remifemin
|
|
|
|
|
REMIFENTANIL ADVANCED INTERMEDIATE
|
|
|
|
|
Remifentanil-13C6 Hydrochloride
|
Remifentanil-13C6 Hydrochloride
|
1189679-87-5
|
C20H29ClN2O5
|
|
REMIFENTANIL
|
瑞芬太尼
|
132875-61-7
|
C20H28N2O5
|
|
Remifentanil Hydrochloride
|
REMIFENTANIL HYDROCHLORIDE SOLUTION
|
132539-07-2
|
C20H28N2O5.ClH
|
|
1R4FCIGARETTES
|
|
|
|
|
rel-(2R,3R)-6-[α-(2-Ethoxy-d5-phenoxy)benzyl]morpholin-3-one
|
REL-(2R,3R)-6-[Α-(2-ETHOXY-D5-PHENOXY)BENZYL]MORPHOLIN-3-ONE
|
1292840-26-6
|
C19H21NO4
|
|
rel-(2R,3R)-2-Hydroxy-N,N,N-trimethylethanaminium 2,3-dihydroxybutanedioate
|
REL-(2R,3R)-2-羟基-N,N,N-三甲基乙铵 2,3-二羟基丁二酸盐
|
132215-92-0
|
C9H19NO7
|
|
rel-3-[(1R,2R)-1-Hydroxy-2-[(MethylaMino)Methyl]cyclohexyl]phenol 1-(Hydrogen Sulfate)
|
|
480452-78-6
|
C14H21NO5S
|
|
rel-3-[(1R,2R)-1-Hydroxy-2-[(MethylaMino)Methyl]cyclohexyl]phenyl β-D-Glucopyranosiduronic Acid
|
|
|
C20H29NO8
|
|
rel-(4R*,5R*)-4,5-Diphenyloxazolidine-2-one
|
|
19190-95-5
|
C15H13NO2
|
|
rel-(4R*,5R*)-2,2-Bis(trifluoromethyl)-4-ethyl-5-hexyl-1,3-dioxolane
|
|
38274-67-8
|
C13H20F6O2
|
|
rel-(1R*,2R*)-1,2-Dibromo-1,2-diphenylethane
|
|
|
|
|
rel-(7R*,8R*)-7,8-Dihydrobenzo[a]pyrene-7,8-diol
|
|
|
|
|
rel-(9R*,10R*)-9,10-Dihydrobenzo[a]pyrene-9,10-diol
|
|
|
|
|
rel-(2R*,3R*)-Oxirane-2,3-dicarboxylic acid diethyl ester
|
|
|
|
|
rel-(1R*,2R*)-1-(3-Methoxy-4-hydroxyphenyl)-2-(3-methoxy-4-hydroxyphenyl)-1,3-propanediol
|
|
|
|
|
rel-(2R*,5R*)-5-Methyltetrahydrofuran-2-methanol
|
16015-08-0
|
16015-08-0
|
C6H12O2
|
|
rel-(1R*,2R*)-2-Phenylcyclopropane-1-carboxylic acid methyl ester
|
(1R,2R)-2-苯基环丙烷甲酸甲酯
|
5861-31-4
|
C11H12O2
|
|
REL-(1R,5R,6S)-3-METHOXYCARBONYL-7-OXABICYCLO[4.1.0]-HEPT-2-EN-5-OL
|
|
78844-86-7
|
C8H10O4
|
|
rel-2-[4-[[(4R,5S)-4,5-Bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl]carbonyl]-1-piperazinyl]-1-(4-morpholinyl)ethanone
|
REL-2-[4-[[(4R,5S)-4,5-双(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧基苯基]-4,5-二氢-4,5-二甲基-1H-咪唑-1-基]羰基]-1-哌嗪基]-1-(4-吗啉基)乙酮
|
939983-14-9
|
C40H49Cl2N5O4
|
|
rel-(R,S)-Voriconazole-d3
|
rel-(R,S)-Voriconazole-d3
|
1217661-14-7
|
C16H14F3N5O
|
|
(rel-R,S)-Bisfuran Alcohol (Mixture of DiastereoMers)
|
(rel-R,S)-Bisfuran Alcohol (Mixture of DiastereoMers)
|
|
C6H10O3
|
|
rel-(1R,5S)-2-cyano-3-azabicyclo[3,3,0]octane
|
REL-(1R,5S)-2-氰基-3-氮杂双环[3,3,0]辛烷
|
1227703-50-5
|
C8H12N2
|
|
rel-(3R*,4S*)-4-Acetyl-3,5,5-trimethylcyclohexene
|
|
41435-93-2
|
C11H18O
|
|
rel-(2R*,5S*)-5-Methyltetrahydrofuran-2-methanol
|
rel-(2R*,5S*)-5-Methyltetrahydrofuran-2-methanol
|
54774-28-6
|
C6H12O2
|
|
rel-(3R*,6S*)-3-Methyl-6-isopropyl-1-cyclohexene
|
|
1124-26-1
|
C10H18
|
|
rel-(1R*,3S*)-3-Aminocyclohexanecarboxylic acid
|
|
|
|
|
rel-(1R*,2S*)-2-Hydroxy-1-cyclohexanecarboxylic acid
|
|
28131-61-5
|
C7H12O3
|
|
rel-(1R*,2S*)-1-(Cyclohexyl)-2-methylcyclohexane
|
|
50991-08-7
|
C13H24
|
|
rel-(2R*,3S*)-2,3-Epoxyheptane
|
|
56052-93-8
|
C7H14O
|
|
rel-(2R*,3S*)-2-Methyl-3-phenyloxirane
|
|
|
|
|
rel-(4R*,5S*)-4,5-Diphenyloxazolidine-2-one
|
|
19202-66-5
|
C15H13NO2
|
|
RELT
|
RELT
|
|
|
|
remikiren
|
|
135669-48-6
|
C33H50N4O6S
|
|
Remikiren
|
瑞米吉仑
|
126222-34-2
|
C33H50N4O6S
|
|
rel-α,α,4α*,5β*-Tetramethyl-1-cyclopentene-1-methanol
|
|
56666-69-4
|
C10H18O
|
|
rel-7,8,9,10-Tetrahydrobenzo[a]pyrene-7β*,8α*,9β*,10α*-tetrol
|
|
|
|
|
rel-1,2,3,4-Tetrahydronaphthalene-1α*,2α*-diol
|
|
21016-53-5
|
C10H12O2
|
|
rel-(-)-(tert-Butyldimethylsiloxy)acetic acid (1S*)-2β*-phenylcyclohexane-1α*-yl ester
|
|
|
|
|
rel-Tetralin-1β*,2α*-diol
|
|
14211-53-1
|
C10H12O2
|
|
Remiprostol
|
瑞前列醇
|
110845-89-1
|
C25H36O5
|
|
rel-(4S*,5R*)-4-Methyl-5-phenyl-4,5-dihydrofuran-2(3H)-one
|
|
|
|
|
rel-(4S*,5S*)-4-Methyl-5-phenyl-4,5-dihydrofuran-2(3H)-one
|
|
|
|
|
Remitan
|
DIETHYL(2-(DIPHENYLACETOXY)-ETHYL)METHYLAMMONIUM BROMIDE
|
6113-04-8
|
C21H28BrNO2
|
|
rel-Stearic acid [(2S*)-2α*-phenyl-1,3-dioxolane]-4α*-ylmethyl ester
|
|
56599-88-3
|
C28H46O4
|
|
RENACITII
|
|
|
|
|
RfbT protein
|
|
|
|
|
RenaGel-d5
|
|
|
C6H12ClNO
|
|
rel-trans-Silandrin
|
|
|
C25H22O9
|
|
rel-(-)-(Triisopropylsiloxy)acetic acid (1S*)-2β*-phenylcyclohexane-1α*-yl ester
|
|
|
|
|
Renaissance
|
|
|
|
|
rel-Valeric acid (1S*)-2α*-methylcyclohexane-1α*-yl ester
|
|
54714-36-2
|
C12H22O2
|
|
rel-Valeric acid (1S*)-2β*-methylcyclohexane-1α*-yl ester
|
|
15287-81-7
|
C12H22O2
|
|
RENALDISEASE
|
|
|
|
|
RENALTOTALPARENTERALNUTRITION
|
|
|
|
|
renal G-protein coupled receptor
|
|
|
|
|
Renal Agents
|
|
|
|
|
renal transplantation unit solution
|
|
|
|
|
renal tubular antigen
|
|
|
|
|
RENALCAREPRODUCTS
|
|
|
|
|
RENALCELLCARCINOMAMARKER,GP200,~200KD,CLONE:PN-15,MABANTI-HUMAN,RAT:PARAFFIN,IH/WB
|
|
|
|
|
RenalCare
|
|
|
|
|
renal-specific transporter RST
|
|
|
|
|
Renalin
|
|
|
|
|
renal osmotic stress-induced transporter
|
|
|
|
|
renal basolateral peptide transporter
|
|
|
|
|
renal NAD(P)H oxidase
|
|
|
|
|
R-ENANTIOMEROFMETALAXYL
|
|
|
|
|
Renanolone
|
雷那诺龙
|
565-99-1
|
C21H32O3
|
|
3R enantiomer
|
(R)1-苯基丁-3-烯-2-基氨基甲酸叔丁酯
|
244092-76-0
|
C15H21NO2
|
|
RfbU protein
|
|
|
|
|
(R-(E))-2-(1-Naphthalenyl)-1-(3-phenyl-2-propenyl)piperidine
|
|
77184-03-3
|
C24H25N
|
|
RdxA protein
|
|
148711-16-4
|
|
|
RENARDINE
|
|
6882-01-5
|
C19H27NO6
|
|
RfcL protein
|
|
|
|
|
RfbV protein
|
|
|
|
|
RdxB protein
|
|
|
|